On the floor at AAO 2023, host Veeral Sheth, MD, and producer Connor Iapoce discuss UBX1325 for patients with diabetic macular edema, based on the 48-week results from the phase 2 BEHOLD study.



Episode Highlights:

0:30 Introduction

0:48 Background into UBX1325 and BEHOLD

2:49 BEHOLD 48-week results

6:05 Next steps

6:56 Conclusion



Please direct any podcast-related inquiries to ciapoce@mjhlifesciences.com.